Sinclair Pharma PLC
SPH
Delayed London Stock Exchange - 06/22 05:35:19 pm
18.575GBp
-1.46%
Prev.18.8500
Open18.6000
High18.6000
Low18.3000
Volume27 364
Financials
Sales 2018 52,1 M
EBIT 2018 0,30 M
R. net 2018 -14,4 M
Debt 2018 11,7 M
Rend. 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 2,05x
EV / Sales 2019 1,56x
Capitalization 95,1 M
Company
Sinclair Pharma Plc is an aesthetic dermatology company, which provides aesthetic dermatology solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring, and dermal fillers for wrinkles and lines.It operates through the following business segments: Country...
Sector :
Generic Pharmaceuticals
Calendar :
2018-09-13 Earnings Release
Trading Rating :
Investor Rating :
Latest news
05/31SINCLAIR PHARMA : Silhouette InstaLift® Wins NewBeauty Magazine Beauty Choice Award
AQ
02/22SINCLAIR PHARMA : announces $5 million investment by EW Healthcare Partners via convertible loan
PU
02/22SINCLAIR PHARMA : and ThermiGen terminate US distribution agreement
PU
01/29SINCLAIR PHARMA : Aesthetic surgery journal confirms efficacy and consumer acceptance of absorbable suture suspension
PU
01/17SINCLAIR PHARMA : Director/PDMR Shareholding
PU
01/16SINCLAIR PHARMA : Ellansé® Approved for Sale in Brazil
PU
01/16SINCLAIR PHARMA : Ellansé Approved for Brazil
PU
01/15SINCLAIR PHARMA : Trading Statement
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBearish
Resistance20,026,121,1
Spread/Res.-7,0%-29%-12%
Spread/Supp.7,2%26%26%
Support17,314,814,8